<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03607360046425</udiDi>
    <basicUdiDi>3607364642BUEC</basicUdiDi>
    <tradeName>HYDRASHIFT 2/4 isatuximab (40 TESTS)</tradeName>
    <deviceName>HYDRASHIFT 2/4 isatuximab (40 TESTS)</deviceName>
    <manufacturerName>sebia</manufacturerName>
    <manufacturerSrn>FR-MF-000003520</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>4642</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:09:29.194Z</lastUpdated>
  </row>
  <row>
    <udiDi>03607360046395</udiDi>
    <basicUdiDi>3607364639BUF8</basicUdiDi>
    <tradeName>HYDRASHIFT 2/4 daratumumab (20 TESTS)</tradeName>
    <deviceName>HYDRASHIFT 2/4 daratumumab (20 TESTS)</deviceName>
    <manufacturerName>sebia</manufacturerName>
    <manufacturerSrn>FR-MF-000003520</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>4639</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:09:28.377Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724627496</udiDi>
    <basicUdiDi>B-50604724627496</basicUdiDi>
    <tradeName>50604724627496</tradeName>
    <deviceName>S.boydii 1-15 2.0 ml</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6903</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:39.497Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724627328</udiDi>
    <basicUdiDi>B-50604724627328</basicUdiDi>
    <tradeName>50604724627328</tradeName>
    <deviceName>S.dysenteriae 1-10 2.0 ml</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6902</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:38.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724627250</udiDi>
    <basicUdiDi>B-50604724627250</basicUdiDi>
    <tradeName>50604724627250</tradeName>
    <deviceName>S.flexneri 1-6 X&amp;Y 2.0 ml</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6901</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:38.312Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724627182</udiDi>
    <basicUdiDi>B-50604724627182</basicUdiDi>
    <tradeName>50604724627182</tradeName>
    <deviceName>S.sonnei Phase 1 &amp; 2 2.0 ml</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6900</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:33.904Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724627014</udiDi>
    <basicUdiDi>B-50604724627014</basicUdiDi>
    <tradeName>Factor z6</tradeName>
    <deviceName>Factor z6</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6157</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:32.494Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626956</udiDi>
    <basicUdiDi>B-50604724626956</basicUdiDi>
    <tradeName>Factor 7</tradeName>
    <deviceName>Factor 7</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6156</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:32.101Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626888</udiDi>
    <basicUdiDi>B-50604724626888</basicUdiDi>
    <tradeName>Factor 6</tradeName>
    <deviceName>Factor 6</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6155</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:31.090Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626710</udiDi>
    <basicUdiDi>B-50604724626710</basicUdiDi>
    <tradeName>Factor 5</tradeName>
    <deviceName>Factor 5</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6154</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:28.318Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626642</udiDi>
    <basicUdiDi>B-50604724626642</basicUdiDi>
    <tradeName>Factor 2</tradeName>
    <deviceName>Factor 2</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6153</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:28.168Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626574</udiDi>
    <basicUdiDi>B-50604724626574</basicUdiDi>
    <tradeName>Factor z29</tradeName>
    <deviceName>Factor z29</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6151</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:27.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626406</udiDi>
    <basicUdiDi>B-50604724626406</basicUdiDi>
    <tradeName>Factor z10</tradeName>
    <deviceName>Factor z10</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6149</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:25.814Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626338</udiDi>
    <basicUdiDi>B-50604724626338</basicUdiDi>
    <tradeName>Factor z32</tradeName>
    <deviceName>Factor z32</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6148</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:20.552Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626260</udiDi>
    <basicUdiDi>B-50604724626260</basicUdiDi>
    <tradeName>Factor z24</tradeName>
    <deviceName>Factor z24</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6147</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:19.687Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626192</udiDi>
    <basicUdiDi>B-50604724626192</basicUdiDi>
    <tradeName>Factor z23</tradeName>
    <deviceName>Factor z23</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6146</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:19.446Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724626024</udiDi>
    <basicUdiDi>B-50604724626024</basicUdiDi>
    <tradeName>z4 Complex</tradeName>
    <deviceName>z4 Complex</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6145</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:19.351Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724625966</udiDi>
    <basicUdiDi>B-50604724625966</basicUdiDi>
    <tradeName>Factor z</tradeName>
    <deviceName>Factor z</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6144</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:15.394Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724625898</udiDi>
    <basicUdiDi>B-50604724625898</basicUdiDi>
    <tradeName>Factor y</tradeName>
    <deviceName>Factor y</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6143</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:14.232Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724625720</udiDi>
    <basicUdiDi>B-50604724625720</basicUdiDi>
    <tradeName>Factor r</tradeName>
    <deviceName>Factor r</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6142</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:22:13.528Z</lastUpdated>
  </row>
</eudamedExport>